Language access services: translation and interpretation
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N98022D00045
- Awardee
-
Prescient Technologies, LLC UEI V6QDML49NW17
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $38,106 obligated
Award facts
- Opportunity
-
- Language Access Services: Translation and Interpretation Solicitation · 75N98022R00004 · Posted Feb 15, 2022
- Combined order value
- $38,106 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 1% used
- $5,453,600.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541930 Translation and Interpretation Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 16 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV awarded to Prescient Technologies, LLC is a $5,453,600 Indefinite Delivery Contract for language access services, including translation and interpretation, in support of the National Cancer Institute's (NCI) "Implementing the President's Department of Government Efficiency Cost Efficiency Initiative." The contract has a period of performance through May 7, 2025 and was set aside for small businesses.
Under this contract, Prescient Technologies will provide a range of language access services to the NCI, including translation of written materials, interpretation services, and support for digital content and multimedia. A recent $38,105.86 firm fixed price delivery order was issued to Prescient to translate 146 pathology reports from Italian to English in support of the NCI's Sherlock-Lung Genomic Epidemiologic Study of Lung Cancer in Never Smokers. Prescient Technologies is a service-disabled veteran-owned small business (SDVOSB) with multiple small business certifications, positioning it to effectively deliver these language access services to the civilian federal agency.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Translation services for the sherlock-lung genomic epidemiologic study of lung cancer in never smokers in support of… | National Cancer Institute (NIH) | $38,106 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N98022D00045?
75N98022D00045 was awarded to Prescient Technologies, LLC by Office of Logisitics and Acquisition Operations (National Institutes of Health) on August 1, 2022.
How much is contract 75N98022D00045 worth?
Orders under 75N98022D00045 have obligated $38,106. 75N98022D00045's own ceiling is $5,453,600.
How many orders have been placed under contract 75N98022D00045?
1 order has been placed under 75N98022D00045, the latest on September 16, 2022.
Who can order from contract 75N98022D00045?
75N98022D00045 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N98022D00045 competed?
The extent of competition for 75N98022D00045 was full and open competition after exclusion of sources. The government received 16 offers. It was set aside: Total Small Business.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV